Keywords: gilead, hepsera, hep, oked, europe, sciences, been

Gilead's Hepsera for hep B OKed in Europe

Article | 17 March 2003

Print This

Gilead Sciences has been granted marketing approval in the EuropeanUnion for Hepsera (adefovir dipivoxil 10mg) in the treatment of chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in